Arrowhead Pharmaceuticals, Inc. (ARWR) stock chart
ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q4 FY2026, quarter ended Sep 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3056% above fair value
$47.15−2.21 (-4.48%)
Close on Nov 12, 2026Market cap $6.66BP/E –Yield –
Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.
See a number that looks wrong?